Skip to main content
Sign In
 

Meet the organizers


Sub-committees:

Steering
Programming
Communication
Finance
Fundraising
Marketing
Technology


STEERING
EtienneDanis.png  
Etienne Danis, PhD
University of Colorado
Anschutz Medical Campus
Dr. Danis earned his PhD in Molecular Biology and Biochemistry from the University of Montpellier in France. He worked as a postdoctoral fellow at the University of California, San Diego on dissecting the role of transcription factors in the epithelial-mesenchymal transition, breast cancer metastasis and liver fibrosis. He currently works at the University of Colorado, Denver on developing and characterizing new mouse models of leukemia based on epigenetic dysregulations observed in human T-cell acute lymphoblastic leukemia to establish more efficient therapies. He is also passionate about strengthening and developing the relationships between academia and industry.

GaryMouradian.png  
Gary C. Mouradian Jr, PhD
Pediatrics, CVP
University of Colorado
Anschutz Medical Campus
Dr. Mouradian’s is a co-organizer and director of programming committee. He is an academic researcher in the field of respiratory physiology focused on pulmonary hypertension and fibrosis. It is a goal and passion of his to identify where his academic training can bring value to companies. He is looking forward to the first RMBTS conference enhancing academic/industry collaborations!

RanjithaDhanasekaran.png  
A Ranjitha Dhanasekaran, PhD
Linda Crnic Institute for Down Syndrome
Department of Pediatrics
School of Medicine
University of Colorado
Anschutz Medical Campus
Dr. Dhanasekaran earned her PhD in Computer Science with an emphasis in Bioinformatics from Utah State University in 2011. She is working as a postdoctoral fellow under the mentorship of Dr. Katheleen Gardiner. Dr. Gardiner's lab focuses on intellectual disability (ID) in Down syndrome (DS). Dr. Dhanasekaran employs her bioinformatics skills to unlock pathway mechanisms that cause ID in DS using Knowledge Discovery in Databases.


PROGRAMMING
GaryMouradian.png  
Gary C. Mouradian Jr, PhD - Director
Pediatrics, CVP
University of Colorado
Anschutz Medical Campus
Dr. Mouradian’s is a co-organizer and director of programming committee. He is an academic researcher in the field of respiratory physiology focused on pulmonary hypertension and fibrosis. It is a goal and passion of his to identify where his academic training can bring value to companies. He is looking forward to the first RMBTS conference enhancing academic/industry collaborations!

EmilyMeredith.jpg  
Emily K Meredith, PhD
University of Colorado
Anschutz Medical Campus
Dr. Meredith earned her Ph.D. in Molecular Biology from the University of Washington in 2012. She is currently working as a postdoctoral fellow in Dr. Aaron Johnson's Lab, where she studies the mechanism of long non-coding RNAs in heterochromatin formation.

male.jpg  
Guankui Wang, PhD
University of Colorado
Anschutz Medical Campus
Dr. Wang's bio

RuiXiong.jpg

 

 

Rui Xiong, Toxicology PhD Candidate
Department of Pharmaceutical Sciences
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Anschutz Medical Campus
Ms. Xiong received her B.S. from China Pharmaceutical University, Nanjing, China in 2009 with a major in Biotechnology and a minor in Pharmaceutical engineering. Her research involves elucidating novel mechanisms of toxicity of xenobiotic and endogenous quinones at the level of protein handling, as well as defining the activity of 19-substituted benzoquinone ansamycin Hsp90 inhibitors to induce changes in protein handling systems that protect against mutant A53T α-synuclein aggregation and toxicity.

female.png  
Ankita Nagvekar
Department of Pharmaceutical Sciences
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Anschutz Medical Campus
Ms. Nagvekar is currently pursuing a PhD in pharmaceutical sciences at University of Colorado Denver. Her areas of interest are formulation development of monoclonal antibodies and protein biochemical and biophysical characterization.

female.png  
Pallavi Bhuyan, Toxicology PhD Candidate
Department of Pharmaceutical Sciences
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Anschutz Medical Campus
Ms. Bhuyan is a native of Kolkata, India and graduated with a Bachelor of Technology degree in Biotechnology in 2008 from the West Bengal University of Technology (India). She then received her M.S degree with graduate assistantship in Pharmacology and Toxicology at the University of Toledo in 2010. Her Master’s thesis work consisted of investigating the role of the detoxifying enzyme sulfotransferase in zebrafish development. In 2010, she joined the Molecular Toxicology PhD program at the University of Colorado Denver and following a year of lab rotations, started working in Dr. Manisha Patel’s lab in 2011. She is currently investigating the role of redox mechanisms in controlling neuroinflammation in temporal lobe epilepsy and nerve-agent toxicity, utilizing both in vitro and in vivo models. She was recently the recipient of the Young Investigator Awards at the annual meeting of the American Epilepsy Society as well as the Gordon Research Conference on mechanisms of epilepsy.

male.jpg  
Eric Logue
University of Colorado
Anschutz Medical Campus
Mr. Eric's bio

EtienneDanis.png  
Etienne Danis, PhD
University of Colorado
Anschutz Medical Campus
Dr. Danis earned his PhD in Molecular Biology and Biochemistry from the University of Montpellier in France. He worked as a postdoctoral fellow at the University of California, San Diego on dissecting the role of transcription factors in the epithelial-mesenchymal transition, breast cancer metastasis and liver fibrosis. He currently works at the University of Colorado, Denver on developing and characterizing new mouse models of leukemia based on epigenetic dysregulations observed in human T-cell acute lymphoblastic leukemia to establish more efficient therapies. He is also passionate about strengthening and developing the relationships between academia and industry.


COMMUNICATION
Dorothy.jpg  
Dorothy Yamamoto, PhD - Co-director
Department of Radiology
School of Medicine
University of Colorado
Anschutz Medical Campus
Dr. Yamamoto received her PhD in Pharmacology (neuroscience emphasis) from the University of Colorado Denver in 2012. During her PhD she studied glutamate receptor function in an animal model of differential cocaine responsiveness. As a post-doc she has moved on to human studies, using imaging techniques combined with behavioral assays to determine brain areas involved in learning and decision-making in clinical populations. She is looking forward to meeting the representatives of the Biotech companies and learning more about the interesting and exciting work going on in Biotechnology here in Colorado.

JohnJanczy.jpg  
John Janczy, PhD - Co-director
Department of Microbiology and Immunology School of Medicine University of Colorado Anschutz Medical Campus
Dr. Janczy is a Postdoctoral Fellow in the lab of Dr. Laurel Lenz. He is from Littleton, CO and earned his B.S. in Biology at Mesa State College, now Colorado Mesa University. He earned his Ph.D. at the University of Iowa under the mentorship of Dr. Fayyaz Sutterwala.  Following his postdoctoral appointment Dr. Janczy is interested perusing a career as a scientist in an industrial setting.

SarahClark.jpg  
Sarah E. Clark, PhD
Department of Microbiology and Immunology
School of Medicine
University of Colorado
Anschutz Medical Campus

Dr. Clark received her doctoral training in the laboratory of Jeffrey N. Weiser, at the University of Pennsylvania, and currently works as a Postdoctoral Fellow in the laboratory of Laurel L. Lenz at UC Denver. Her research focuses on host-pathogen interactions, and she is currently investigating how the bacterium Listeria monocytogenes manipulates the immune response during infection. She is interested in building stronger ties between scientists working in industry and academia.


male.jpg  
Tom Plucinak
University of Colorado
Anschutz Medical Campus
Mr. Plucinak's bio

NuriaPadillaJust.jpg  
Nuria Padilla Just
University of Colorado
Anschutz Medical Campus
Ms. Nuria Padilla Just received her M.S. in translational research and clinical trial monitoring from the University of Barcelona, Spain in 2012. The focus of her dissertation is to understand at molecular, biological and clinical level the impact of NOTCH1 mutations in order to enhance the development of therapeutic agents to prolong the lifespan head and neck squamous cell carcinoma patients.


FINANCE
RanjithaDhanasekaran.png  
A Ranjitha Dhanasekaran, PhD - Director
Linda Crnic Institute for Down Syndrome
Department of Pediatrics
School of Medicine
University of Colorado
Anschutz Medical Campus
Dr. Dhanasekaran earned her PhD in Computer Science with an emphasis in Bioinformatics from Utah State University in 2011. She is working as a postdoctoral fellow under the mentorship of Dr. Katheleen Gardiner. Dr. Gardiner's lab focuses on intellectual disability (ID) in Down syndrome (DS). Dr. Dhanasekaran employs her bioinformatics skills to unlock pathway mechanisms that cause ID in DS using Knowledge Discovery in Databases.

female.png  
Pallavi Bhuyan, Toxicology PhD Candidate
Department of Pharmaceutical Sciences
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Anschutz Medical Campus
Ms. Bhuyan is a native of Kolkata, India and graduated with a Bachelor of Technology degree in Biotechnology in 2008 from the West Bengal University of Technology (India). She then received her M.S degree with graduate assistantship in Pharmacology and Toxicology at the University of Toledo in 2010. Her Master’s thesis work consisted of investigating the role of the detoxifying enzyme sulfotransferase in zebrafish development. In 2010, she joined the Molecular Toxicology PhD program at the University of Colorado Denver and following a year of lab rotations, started working in Dr. Manisha Patel’s lab in 2011. She is currently investigating the role of redox mechanisms in controlling neuroinflammation in temporal lobe epilepsy and nerve-agent toxicity, utilizing both in vitro and in vivo models. She was recently the recipient of the Young Investigator Awards at the annual meeting of the American Epilepsy Society as well as the Gordon Research Conference on mechanisms of epilepsy.

male.jpg  
Eric Logue
University of Colorado
Anschutz Medical Campus
Mr. Logue's bio


FUNDRAISING
female.png  
Svenja Heischmann, PhD - Co-director
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Anschutz Medical Campus
Dr. Heischmann received her PhD in analytical chemistry and biochemistry at the University of Bremen, Germany. Her PhD studies were conducted at the University of Colorado Denver in the Department of Anesthesiology, where she utilized a combination of proteomics and metabolomics strategies for the elucidation of molecular mechanisms underlying immunosuppressant drug toxicity.  Currently, Svenja is a postdoctoral researcher engaging in epilepsy research with a focus on biomarker discovery and validation.

EtienneDanis.png  
Etienne Danis, PhD - Co-director
University of Colorado
Anschutz Medical Campus
Dr. Danis earned his PhD in Molecular Biology and Biochemistry from the University of Montpellier in France. He worked as a postdoctoral fellow at the University of California, San Diego on dissecting the role of transcription factors in the epithelial-mesenchymal transition, breast cancer metastasis and liver fibrosis. He currently works at the University of Colorado, Denver on developing and characterizing new mouse models of leukemia based on epigenetic dysregulations observed in human T-cell acute lymphoblastic leukemia to establish more efficient therapies. He is also passionate about strengthening and developing the relationships between academia and industry.

RuiXiong.jpg  
Rui Xiong, Toxicology PhD Candidate
Department of Pharmaceutical Sciences
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Anschutz Medical Campus

Ms. Xiong received her B.S. from China Pharmaceutical University, Nanjing, China in 2009 with a major in Biotechnology and a minor in Pharmaceutical engineering. Her research involves elucidating novel mechanisms of toxicity of xenobiotic and endogenous quinones at the level of protein handling, as well as defining the activity of 19-substituted benzoquinone ansamycin Hsp90 inhibitors to induce changes in protein handling systems that protect against mutant A53T α-synuclein aggregation and toxicity.


NuriaPadillaJust.jpg  
Nuria Padilla Just
University of Colorado
Anschutz Medical Campus
Ms. Nuria Padilla Just received her M.S. in translational research and clinical trial monitoring from the University of Barcelona, Spain in 2012. The focus of her dissertation is to understand at molecular, biological and clinical level the impact of NOTCH1 mutations in order to enhance the development of therapeutic agents to prolong the lifespan head and neck squamous cell carcinoma patients.


MARKETING
TimBoyd2.jpg  
Tim Boyd, PhD - Co-director
Department of Neurology
School of Medicine
University of Colorado
Anschutz Medical Campus

Dr. Boyd received his PhD, MSB from the University of South Florida, where he helped to discover the new use for a FDA-approved drug in treating Alzheimer's disease and to initiate its investigation in ongoing clinical trials, as well as in consulting and fostering corporate sponsorship for its advancement through trials, and for the commercialization of its IP. He is also currently working on an MBA in Finance at the CU Auraria campus, which he hopes will help him with his role on this planning committee as Director of Marketing for the RMBTS event.


EtienneDanis.png  
Etienne Danis, PhD - Co-director
University of Colorado
Anschutz Medical Campus
Dr. Danis earned his PhD in Molecular Biology and Biochemistry from the University of Montpellier in France. He worked as a postdoctoral fellow at the University of California, San Diego on dissecting the role of transcription factors in the epithelial-mesenchymal transition, breast cancer metastasis and liver fibrosis. He currently works at the University of Colorado, Denver on developing and characterizing new mouse models of leukemia based on epigenetic dysregulations observed in human T-cell acute lymphoblastic leukemia to establish more efficient therapies. He is also passionate about strengthening and developing the relationships between academia and industry.

female.png  
Tian Yu, PhD
Division of Endocrinology, Metabolism and Diabetes
School of Medicine
University of Colorado
Anschutz Medical Campus
Dr. Yu, originally from China, got her Ph.D degree from Utah State University in 2010 and is currently a postdoctoral fellow at the University of Colorado, School of Medicine, Division of Endocrinology.


TECHNOLOGY
RanjithaDhanasekaran.png  
A Ranjitha Dhanasekaran, PhD - Director
Linda Crnic Institute for Down Syndrome
Department of Pediatrics
School of Medicine
University of Colorado
Anschutz Medical Campus
Dr. Dhanasekaran earned her PhD in Computer Science with an emphasis in Bioinformatics from Utah State University in 2011. She is working as a postdoctoral fellow under the mentorship of Dr. Katheleen Gardiner. Dr. Gardiner's lab focuses on intellectual disability (ID) in Down syndrome (DS). Dr. Dhanasekaran employs her bioinformatics skills to unlock pathway mechanisms that cause ID in DS using Knowledge Discovery in Databases.


© The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.